GSK press releases Follow GSK announces FIRST trial met its primary endpoint of progression free survival in first line advanced ovarian cancer GSK announces headline results from the FIRST-ENGOT-OV44 phase III trial. https://www.gsk.com/en-gb/media/press-releases/gsk-announces-first-trial-met-its-primary-endpoint-of-progression-free-survival-in-first-line-advanced-ovarian-cancer/ gsk.com
